Validity and Reliability of the French Translation of the Richards-Campbell Questionnaire

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

190 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-01

Study Completion Date

2026-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The validation of a sleep questionnaire (translated into French from a source questionnaire in English) will provide a reliable and easily administered tool for assessing sleep quality in intensive care, enabling better identification of patients at risk of sleep disorders and other associated complications, in particular ventilatory weaning difficulties.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Patients' Sleep at the Intensive Care Unit

NCT03856489

Sleep Quality of ICU Patients

COMPLETED

Impact of a Multifaceted Intervention of Environment Control in the ICU to Optimize Quantity and Quality of Sleep

NCT05694052

Sleep Disturbance

COMPLETED NA

Assessment of Sleep Quality of Hospitalized Patients Treated With EEG-guided Protection Procedures: Application in Intensive Care Unit

NCT05963672

Sleep Quality Critically Ill Patient Intensive Care Unit

COMPLETED NA

Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance

NCT01061242

Neurobehavioral Manifestations Sleep Deprivation Dyssomnias

COMPLETED NA

Sleep Quantity and Quality in the ICU: a Prospective Observational Stud

NCT03796338

Sleep Disturbance Critical Illness

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sleep disturbance in intensive care is influenced by a number of factors, such as environmental nuisances (noise, light, repeated interruptions), treatments (sedation, analgesia, mechanical ventilation) and the severity of the acute pathology that led to admission. Consequences include alterations to the immune system, neuropsychiatric disorders and impaired functional recovery.

Current management of these disorders remains limited:

* No pharmacological treatment has clearly demonstrated its efficacy on sleep quality in intensive care.
* Interventions aimed at modulating environmental nuisances (reducing noise, reducing light exposure, respecting day/night cycles) have shown limited effects.
* According to the available data, individual devices (eye masks, earplugs) have not significantly improved sleep architecture.

In this context, the Richards-Campbell questionnaire (RCSQ) represents an interesting alternative for subjectively assessing sleep in intensive care patients. This questionnaire, specifically designed for these patients, provides a simple and rapid assessment of sleep disturbances. The validation of a French version of the RCSQ meets a need to standardise assessment practices in France and to gain a better understanding of the factors influencing sleep quality in intensive care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Disorders Not Due to A Substance or Known Physiological Condition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Validation of sleep quality by the Richards-Campbell Sleep Questionnaire (RCSQ) in french version

The RCSQ questionnaire translated into French (RCSQ-F) will be distributed to intensive care patients who meet the inclusion and non-inclusion criteria and who have given their informed consent to participate in the study.

The questionnaire will be distributed on two occasions: at the first visit and on the day of discharge from intensive care for survivors, or at the latest on the 14th day of hospitalisation.

Patients' use of the questionnaire will enable internal validation (primary objective) by exploratory factor analysis.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged ≥ 18 years
* Hospitalised in intensive care for at least 24 hours
* Able to understand and answer questionnaires
* Unsedated (discontinued for 24 hours) presenting a Richmond Sedation Agitation Scale score between ≥-2 and ≤ +1
* Fluent in French
* Having given oral consent for participation in the study
* Person affiliated to a social security scheme.

Exclusion Criteria

* Patient refusal
* Person deprived of liberty by an administrative or judicial decision or protected adult subject (under guardianship or curatorship)
* Patient unable, for whatever reason, to read, understand or answer the questionnaires (visual problems, psychiatric or cognitive problems, etc.)
* Patient already included in the study or another study evaluating sleep

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No